Efficacy and safety of durvalumab and gemcitabine-based chemotherapy combined with or without lenvatinib in advanced biliary tract cancer.

被引：0
|
作者：
Ding, Qi
Sun, Yubei [1 ]
Wang, Gang [2 ]
Song, Ruipeng
机构：
[1] Anhui Prov Hosp, Hefei, Anhui, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gemcitabine-based chemotherapy for advanced biliary tract carcinomas
    Abdel-Rahman, Omar
    Elsayed, Zeinab
    Elhalawani, Hesham
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (04):
  • [2] Treatment patterns of gemcitabine-based chemotherapy in patients with de novo and recurrent advanced biliary tract cancer.
    Dayyani, Farshid
    Stirnadel-Farrant, Heide A.
    Hu, Jenny
    Lin, Yian
    Kebede, Nehemiah
    Valerio, Stephen J.
    Ahn, Daniel H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 454 - 454
  • [3] TOURMALINE: A phase 3b study of durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer
    Vogel, Arndt
    He, Aiwu Ruth
    Oh, Do-Youn
    Macarulla, Teresa
    Dane, Aaron
    Nguyen, Binh
    Wetherill, Graham
    Baur, Boris
    Ikeda, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: A meta-analysis
    Liu, Heng
    Zhang, Qi-Di
    Li, Zheng-Hong
    Zhang, Qing-Qing
    Lu, Lun-Gen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (47) : 18001 - 18012
  • [5] Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer:A meta-analysis
    Heng Liu
    Qi-Di Zhang
    Zheng-Hong Li
    Qing-Qing Zhang
    Lun-Gen Lu
    World Journal of Gastroenterology, 2014, (47) : 18001 - 18012
  • [6] Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy
    Lee, Sunyoung
    Shroff, Rachna T.
    Makawita, Shalini
    Xiao, Lianchun
    De Armas, Anaemy Danner
    Bhosale, Priya
    Reddy, Kavitha
    Shalaby, Ahmed
    Raghav, Kanwal
    Pant, Shubham
    Wolff, Robert A.
    Javle, Milind
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2229 - 2236
  • [7] Gemcitabine-based chemotherapy in advanced-metastatic and/or unresectable pancreatic cancer.
    Samelis, GF
    Areovimata, A
    Matsiakou, F
    Zografos, G
    Papakostas, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 376S - 376S
  • [8] A retrospective analysis of efficacy and safety of lenvatinib combined with PD-1 inhibitor and chemotherapy in advanced biliary tract cancer (BTC).
    Li, Hu
    Meng, Lingzhan
    Yu, Peng
    Cao, Li
    Wang, Zizheng
    Yan, Jin
    Shao, Yanling
    Shi, Bin
    Zhu, Zhenyu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
    Mi-Jung Kim
    Do-Youn Oh
    Se-Hoon Lee
    Dong-Wan Kim
    Seock-Ah Im
    Tae-You Kim
    Dae Seog Heo
    Yung-Jue Bang
    BMC Cancer, 8
  • [10] EFFICACY AND SAFETY OF GEMCITABINE PLUS CISPLATIN CHEMOTHERAPY FOR ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE STUDY
    Hirano, G.
    Takii, Y.
    Kamihira, T.
    Fujisawa, K.
    Ichiki, Y.
    Suzuki, T.
    Matsuo, T.
    Uraoka, S.
    Aoki, K. -I.
    Sakai, K. -I.
    Ogawa, R.
    Higuchi, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 121 - 121
12345